Clinical TrialsSearch results
Number of results: 68732
Other
- A Phase I/Ib, Open-label, Multi-center Study of DFF332 as a Single Agent and in Combination With Everolimus or IO Agents in Patients With Advanced/Relapsed ccRCC and Other Malignancies With HIF2alpha Stabilizing Mutations
- Carcinoma, Renal Cell
- Yonemura Masataka
- 2021-08-13
Other
- Study of safety and preliminary efficacy of VAY736 given alone or in combination with other antineoplastic agents in patients with NHL
- Non-Hodgiking Lymphoma
- Yonemura Masataka
- 2021-08-13
Recruiting
- Study of JDQ443 in patients with advanced solid tumors harboring the KRAS G12C mutation
- KRAS G12C Mutant Solid Tumors, Carcinoma;Non-Small-Cell Lung, Carcinoma;Colorectal
- Yonemura Masataka
- 2021-03-01
Recruiting
- Study of safety and efficacy of KFA115 alone or in combination with pembrolizumab in patients with select advanced cancers
- Advanced or metastatic disease
- Yonemura Masataka
- 2023-10-17
Other
- AMBITION study
- Breast Cancer
- Yonemori Kan
- 2021-01-29
Other
- NCCH1907/MK008 trial
- unresectable alveolar soft tissue sarcoma
- Yonemori Kan
- 2020-06-01
Other
- NCCH2107/MK012 trial
- Epithelioid Sarcoma
- Yonemori Kan
- 2022-12-20
Recruiting
- JCOG2205-TN-1: Sustainable and Efficient Platform of New Therapeutic Development for Early Breast Cancer (S-FACT) Triple-negative breast cancer cohort (TN-1)
- Clinical stage II or III, resectable breast cancer
- Yonemori Kan
- 2024-06-13
Recruiting
- JCOG2205: Sustainable and Efficient Platform of New Therapeutic Development for Early Breast Cancer (S-FACT)
- Clinical stage II or III, resectable breast cancer
- Yonemori Kan
- 2024-06-13
Recruiting
- Reliability, validity and responsiveness of the ICU Medical Research Council-sum score and changing of muscle strength in the Intensive Care Unit.
- Patients who admitted in the ICU
- Yonemori Hospital
- 2021-06-24